EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Evidence-Based Medicine 2006;11:111; doi:10.1136/ebm.11.4.111
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, J. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J. W, Jr
Topic Collections
Right arrowRelevant Article

Therapeutics

Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older people

Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med 2006;354:1130–8.[Abstract/Free Full Text]

Q In older patients with major depression who respond to treatment, does maintenance therapy with paroxetine, psychotherapy, or a combination prevent recurrence of depression?

Clinical impact ratings IM/Ambulatory care ******{star} Psychiatry ******{star} Geriatrics ******{star} GP/FP/Primary care ******{star}

Key Words: depressive disorder (major) • paroxetine • psychotherapy • serotonin uptake inhibitors

The first 150 words of the full text of this article appear below.

METHODS
Formula Design randomised, 2 x 2 factorial design, placebo controlled trial.

Formula Allocation {concealed*}{dagger}.

Formula Blinding blinded (clinicians, patients, and outcome assessors).* Clinicians and patients were not blinded to the psychotherapy intervention.

Formula Follow up period 2 years.

Formula Setting specialised university-based clinic in Pittsburgh, Pennsylvania, USA.

Formula Patients 116 patients >=70 years of age (mean age 77 y, 65% women) who had major depression according to the DSM-IV criteria, score >=15 on the Hamilton Rating Scale for Depression (HRSD) (range 0–52 [worst]), score >=17 on the Folstein Mini-Mental State Examination (range 0–30 [best]), and a sustained clinical response after several months of treatment with paroxetine, 10–40 mg/day, and psychotherapy (weekly, then biweekly).

Formula Intervention paroxetine plus psychotherapy (n = 28), paroxetine plus clinical care (n = 35), placebo plus psychotherapy (n = 35), or placebo plus clinical care (n = 18) for 2 years. Paroxetine was continued at the individually titrated dose. Psychotherapy or clinical . . . [Full text of this article]

John W Williams, Jr, MD, MHS

Duke University Medical Center, Durham, North Carolina, USA


Relevant Article

Glossary
Evid. Based Med. 2006 11: 127. (in Glossary) [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.